This inventor holds 1 USPTO granted patent. Top assignee: Singapore Health Services Pte Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hui Sun Leong: Innovator in Tyrosine Kinase Inhibition
Introduction
Hui Sun Leong is a notable inventor based in Singapore, recognized for his contributions to the field of medical research. He has developed innovative methods that enhance the effectiveness of treatments involving tyrosine kinase inhibitors. His work is particularly significant in the context of cancer therapies.
Latest Patents
Hui Sun Leong holds a patent for a method titled "Method of Modulating Sensitivity to Tyrosine Kinase Inhibitor." This patent represents a crucial advancement in the modulation of drug sensitivity, potentially leading to improved patient outcomes in cancer treatment. He has 1 patent to his name.
Career Highlights
Leong is currently employed at Singapore Health Services Pte Ltd, where he continues to engage in groundbreaking research. His role at this esteemed institution allows him to collaborate with other experts in the field and contribute to significant advancements in healthcare.
Collaborations
Hui Sun Leong has worked alongside talented colleagues, including Fui Teen Chong and Dorival Mendes Rodrigues-junior. These collaborations have fostered a dynamic research environment, enhancing the potential for innovative breakthroughs.
Conclusion
Hui Sun Leong's work in modulating sensitivity to tyrosine kinase inhibitors exemplifies the impact of innovative research in medicine. His contributions are paving the way for advancements in cancer treatment, showcasing the importance of collaboration and innovation in the healthcare sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile